Literature DB >> 29491156

Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.

Smita Nair1, Adam Zlotnick2.   

Abstract

Cytidine deaminases inhibit replication of a broad range of DNA viruses by deaminating cytidines on single-stranded DNA (ssDNA) to generate uracil. While several lines of evidence have revealed hepatitis B virus (HBV) genome editing by deamination, it is still unclear which nucleic acid intermediate of HBV is modified. Hepatitis B virus has a relaxed circular double-stranded DNA (rcDNA) genome that is reverse transcribed within virus cores from a RNA template. The HBV genome also persists as covalently closed circular DNA (cccDNA) in the nucleus of an infected cell. In the present study, we found that in HBV-producing HepAD38 and HepG2.2.15 cell lines, endogenous cytidine deaminases edited 10 to 25% of HBV rcDNA genomes, asymmetrically with almost all mutations on the 5' half of the minus strand. This region corresponds to the last half of the minus strand to be protected by plus-strand synthesis. Within this half of the genome, the number of mutations peaks in the middle. Overexpressed APOBEC3A and APOBEC3G could be packaged in HBV capsids but did not change the amount or distribution of mutations. We found no deamination on pregenomic RNA (pgRNA), indicating that an intact genome is encapsidated and deaminated during or after reverse transcription. The deamination pattern suggests a model of rcDNA synthesis in which pgRNA and then newly synthesized minus-sense single-stranded DNA are protected from deaminase by interaction with the virus capsid; during plus-strand synthesis, when enough dsDNA has been synthesized to displace the remaining minus strand from the capsid surface, the single-stranded DNA becomes deaminase sensitive.IMPORTANCE Host-induced mutation of the HBV genome by APOBEC proteins may be a path to clearing the virus. We examined cytidine-to-thymidine mutations in the genomes of HBV particles grown in the presence or absence of overexpressed APOBEC proteins. We found that genomes were subjected to deamination activity during reverse transcription, which takes place within the virus capsid. These observations provide a direct insight into the mechanics of reverse transcription, suggesting that newly synthesized dsDNA displaces ssDNA from the capsid walls, making the ssDNA accessible to deaminase activity.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  APOBEC3A; APOBEC3G; DNA packaging; hepatitis B virus; reverse transcription

Mesh:

Substances:

Year:  2018        PMID: 29491156      PMCID: PMC5923076          DOI: 10.1128/JVI.02190-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

Review 1.  New perspectives in the therapy of chronic hepatitis B.

Authors:  Pietro Lampertico; Yun Fan Liaw
Journal:  Gut       Date:  2012-05       Impact factor: 23.059

2.  The conformation of double-stranded DNA inside bacteriophages depends on capsid size and shape.

Authors:  Anton S Petrov; Mustafa Burak Boz; Stephen C Harvey
Journal:  J Struct Biol       Date:  2007-08-29       Impact factor: 2.867

3.  Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.

Authors:  Lela Lackey; Emily K Law; William L Brown; Reuben S Harris
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

4.  Complementarity between epsilon and phi sequences in pregenomic RNA influences hepatitis B virus replication efficiency.

Authors:  Claudia E Oropeza; Alan McLachlan
Journal:  Virology       Date:  2006-10-23       Impact factor: 3.616

5.  Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A.

Authors:  Michael A Carpenter; Ming Li; Anurag Rathore; Lela Lackey; Emily K Law; Allison M Land; Brandon Leonard; Shivender M D Shandilya; Markus-Frederik Bohn; Celia A Schiffer; William L Brown; Reuben S Harris
Journal:  J Biol Chem       Date:  2012-08-15       Impact factor: 5.157

6.  High expression of APOBEC3G in patients infected with hepatitis C virus.

Authors:  Yoshihiro Komohara; Hirohisa Yano; Shigeki Shichijo; Kunitada Shimotohno; Kyogo Itoh; Akira Yamada
Journal:  J Mol Histol       Date:  2006-10-12       Impact factor: 2.611

7.  Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences.

Authors:  Andrew E Armitage; Aris Katzourakis; Tulio de Oliveira; John J Welch; Robert Belshaw; Kate N Bishop; Beatrice Kramer; Andrew J McMichael; Andrew Rambaut; Astrid K N Iversen
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.

Authors:  Jean-Pierre Vartanian; Michel Henry; Agnès Marchio; Rodolphe Suspène; Marie-Ming Aynaud; Denise Guétard; Minerva Cervantes-Gonzalez; Carlo Battiston; Vincenzo Mazzaferro; Pascal Pineau; Anne Dejean; Simon Wain-Hobson
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

Review 9.  Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

Authors:  Lars Petter Jordheim; David Durantel; Fabien Zoulim; Charles Dumontet
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

Review 10.  Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).

Authors:  Xiuting He; Jie Li; Jing Wu; Manli Zhang; Pujun Gao
Journal:  Mol Med Rep       Date:  2015-09-10       Impact factor: 2.952

View more
  10 in total

1.  Core Protein-Directed Antivirals and Importin β Can Synergistically Disrupt Hepatitis B Virus Capsids.

Authors:  Christine Kim; Lauren F Barnes; Christopher J Schlicksup; Angela J Patterson; Brian Bothner; Martin F Jarrold; Che-Yen Joseph Wang; Adam Zlotnick
Journal:  J Virol       Date:  2021-10-27       Impact factor: 6.549

Review 2.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

3.  Use of a Fluorescent Analogue of a HBV Core Protein-Directed Drug To Interrogate an Antiviral Mechanism.

Authors:  Smita Nair; Lichun Li; Samson Francis; William W Turner; Michael VanNieuwenhze; Adam Zlotnick
Journal:  J Am Chem Soc       Date:  2018-10-30       Impact factor: 15.419

4.  Effects of Moloney Leukemia Virus 10 Protein on Hepatitis B Virus Infection and Viral Replication.

Authors:  Maritza N Puray-Chavez; Mahmoud H Farghali; Vincent Yapo; Andrew D Huber; Dandan Liu; Tanyaradzwa P Ndongwe; Mary C Casey; Thomas G Laughlin; Mark Hannink; Philip R Tedbury; Stefan G Sarafianos
Journal:  Viruses       Date:  2019-07-17       Impact factor: 5.048

Review 5.  Mapping the Interactions of HBV cccDNA with Host Factors.

Authors:  Nur K Mohd-Ismail; Zijie Lim; Jayantha Gunaratne; Yee-Joo Tan
Journal:  Int J Mol Sci       Date:  2019-09-01       Impact factor: 5.923

6.  Replenishment of Hepatitis B Virus cccDNA Pool Is Restricted by Baseline Expression of Host Restriction Factors In Vitro.

Authors:  Sergey Brezgin; Anastasiia Kostyusheva; Ekaterina Bayurova; Ilya Gordeychuk; Maria Isaguliants; Irina Goptar; Anastasiia Nikiforova; Valery Smirnov; Elena Volchkova; Dieter Glebe; Dmitry Kostyushev; Vladimir Chulanov
Journal:  Microorganisms       Date:  2019-11-06

Review 7.  The Role of APOBECs in Viral Replication.

Authors:  Wendy Kaichun Xu; Hyewon Byun; Jaquelin P Dudley
Journal:  Microorganisms       Date:  2020-11-30

8.  Viral Phrenology.

Authors:  David P Wilson; Danielle A Roof
Journal:  Viruses       Date:  2021-10-30       Impact factor: 5.048

9.  Cancer Evo-Dev: A Theory of Inflammation-Induced Oncogenesis.

Authors:  Wenbin Liu; Yang Deng; Zishuai Li; Yifan Chen; Xiaoqiong Zhu; Xiaojie Tan; Guangwen Cao
Journal:  Front Immunol       Date:  2021-11-22       Impact factor: 7.561

10.  Clearing of Foreign Episomal DNA from Human Cells by CRISPRa-Mediated Activation of Cytidine Deaminases.

Authors:  Sergey Brezgin; Anastasiya Kostyusheva; Natalia Ponomareva; Viktoriia Volia; Irina Goptar; Anastasiya Nikiforova; Igor Shilovskiy; Valery Smirnov; Dmitry Kostyushev; Vladimir Chulanov
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.